Volume 26, Issue 7 (10-2019)                   RJMS 2019, 26(7): 57-65 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sarboozi Hossain Abadi T, Beyzaei H, Hashmi S, Ghasemi B, Smaily A. Study of the inhibitory effects of n-heterocycles, magnesium oxide nanoparticles, nisin and poly-l-lysine on Enterobacter aerogenes (hospital pathogen). RJMS 2019; 26 (7) :57-65
URL: http://rjms.iums.ac.ir/article-1-5505-en.html
Students Research Committee, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran , amir.smaily7299@gmail.com
Abstract:   (3865 Views)
Background: Enterobacter aerogenes (E. aerogenes) is one of the causes of hospital-acquired infections, which its standard strains quickly become resistant to the antibiotics. The discovery of new inhibitory agents against this pathogen is constantly expanding. In this study, the inhibitory effects of several synthetic chemical compounds including magnesium oxide nanoparticles and thiazole, imidazolidine and tetrahydropyrimidine derivatives and natural compounds including nisin and poly-L-lysine were evaluated against E. aerogenes.
Methods: The project is an experimental study. Solutions of all compounds with a specific initial concentration were prepared in 10% DMSO. Antibiogram tests were performed by disc diffusion and broth micro dilution methods according to CLSI guidelines.
Results: Thiazole and tetrahydropyrimidine derivatives, magnesium oxide nanoparticles, nisin and poly-L-lysine had no inhibitory effects on E. aerogenes. Only, imidazolidines 10a and 10c were effective against E. aerogenes with Inhibition Zone Diameter (IZD) = 6.12 and 11.52 mm, Minimum Inhibitory Concentration (MIC) = 1024 and 256 μg/ml, and Minimum Bactericidal Concentration (MBC) = 2048 and 512 μg/ml, respectively.
Conclusion: The inhibitory effects of imidazolidines10a and 10c were proved on the standard strains of E. aerogenes. Design and synthesis of new and more effective derivatives having imidazolidine skeletons can be considered in future studies.
Full-Text [PDF 838 kb]   (1085 Downloads)    
Type of Study: Research | Subject: Laboratory Sciences

1. 1. Thiolas A, Bollet C, La Scola B, Raoult D, Pagès JM. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother; 2005.9(4):1354-8.
2. 2. Ghasemi B, Beyzaie H, Majidiani H. A comparative study on the antibacterial effects of some newly synthesized thiazole, imidazolidine and tetrahydropyrimidine derivatives against Bacillus cereus and Salmonella typhimurium. Pharm Sci; 2016.22(1):54-9.
3. 3. Bakavoli, M, Beyzaei H, Rahimizadeh, M, Eshghi H. Regioselective synthesis of 2[(E)-
4. (benzo[d]thiazol2 (3H)ylidene)(cyano)methyl] thiazoles. Heterocycl Commun; 2011.17:151-4.
5. 4.‌Ghasemi B, Najimi M. Study of antibacterial effect of thiazole derivatives on Rhodoccocusequi, Brucellaabortus and Pasteurellamultocida. Iran J Vet Med; 2016. 10(1):47-52.
6. 5. Ghasemi B, Beyzaei H, Hashemi H. Study of antibacterial effect of novel thiazole, imidazole, and tetrahydropyrimidine derivatives against Listeria monocytogenes. J Med Bacteriol; 2015.13:101-5.
7. 6. Lv P, Wang K, Yang Y, Mao W, Chen J, Xiong J, et al. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. Bioorg Med Chem Lett; 2009.19:6750-4.
8. 7. Berg AK, Myrvik MJ, Van Ess PJ. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults. Epilepsy Behav; 2017.71:51-9.
9. 8. Nascimento FA, Takeshita BT, Kowacs PA. Phenytoin-induced isolated chronic, nocturnal dry cough. Epilepsy Behav Case Rep; 2017.;5:44-5
10. 9. Kujawski J, Czaja K, Jodtowska-Siewert E, Dettlaff K, Zwawiak J, Kujawski R, et al. Structural and spectroscopic properties of itraconazole and ketoconazole –Experimental and theoretical studies. J Mol Struct; 2017.1146:259-66.
11. 10. Ghasemi B, Beyzaei H, Najimi M. [The antibacterial effects of the new derivatives of thiazole, imidazole and tetrahydropyridine against Proteus vulgaris: an in vitro study]. Pars J Med Sci; 2016.13(4):47-55. [Persian].
12. 11. Kim HS, Jadhav JR, Jung SJ, Kwak JH. Synthesis and antimicrobial activity of imidazole and pyridine appended cholestane-based conjugates. Bioorg Med Chem Lett; 2013.23:4315-8.
13. 12. Beyzaei H, Ghasemi B, Askari V. Antibacterial evaluation of new thiazole, imidazolidine and tetrahydropyrimidine derivatives against pathogenic gram-negative bacteria. J Isfahan Med Sch; 2015.33(353):1662-71.
14. 13. Akhaja TN, Raval JP. Design, synthesis, in vitro evaluation of tetrahydropyrimidine isatin hybrids as potential antibacterial, antifungal and anti-tubercular agents. Chinese Chem Lett; 2012.23:446-9.
15. 14. Ghasemi B,Najimi M, Beyzaie H, Mirzai M, Majidiani H, Nasiri M. Evaluation of antibacterial effects of silver nanoparticles with thiazole, imidazole and tetrahydropyridine derivatives against hospital gram negative bacterial pathogens. Iran J Med Microbiol; 2016.10(4):34-42.
16. 15. Mamatha R, Khan S, Salunkhe P, Satpute S, Kendurkar SV, Prabhune A, et al. Rapid synthesis of highly monodispersed silver nanoparticles from the leaves of Salvadorapersica. Mater Lett; 2017.205:226-9.
17. 16. Tang ZX, Lv BF. MgO nanoparticles as antibacterial agent: preparation and activity. Braz J Chem Eng; 2014.31(3):591-601.
18. 17. Samadi M, Shekarforoush S S, Ghaisari H R. [Antimicrobial effects of magnesium oxide nanoparticles and ε-poly-L-lysine against Escherichia coli O157:H7 and Listeria monocytogenes]. Iran J Med Microbiol; 2016.10(2):33-41. [Persian].
19. 18. Pan D, Zhang D, Hao L, Lin S, Kang Q, Liu X, et al. Protective effects of soybean protein and egg white protein on the antibacterial activity of nisin in the presence of trypsin. Food Chem; 2017.239:196-200.
20. 19. Safari R, Yaghoubzadeh Z. The combined effect of nisin, sodium acetate to increase the shelf life of trout in form completely empty stomach. Iran Sci Fish J; 2016.24(4):155-69.
21. 20. Beyzaei H , Aryan R, Molashahi H, Zahedi MM, Samzadeh‑Kermani A, Ghasemi B. MgO nanoparticle‑catalyzed, solvent‑free Hantzsch synthesis and antibacterial evaluation of new substituted thiazoles. J Iran Chem Soc; 2017.14(5):1023-31
22. 21. Beyzaei H, Kooshki S, Aryan R, Zahedi MM, Samzadeh-Kermani A, Ghasemi B. MgO nanoparticle-catalyzed synthesis and broad-spectrum antibacterial activity of imidazolidine and tetrahydropyrimidine-2-thione derivatives. Appl Biochem Biotech; 2018.184(1):291-302.
23. 22. Beyzaei H, Ghasemi B, Moghadam Manesh M. [Study of antibacterial effect of new thiazole, thiazolidine, imidazole, tetrahydropyrimidine, oxazolidine and thiazepine derivatives against Enterococcus faecalis]. Yafteh; 2016.18(3):68-77. [Persian].
24. 23. Asghari F, Jahanshiri Z, Imani M, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Antifungal nanomaterials: synthesis, properties, and applications. 2016.6:343-83.
25. 24. Krishnamoorthy K, Manivannan G, Kim SJ, Jeyasubramanian K, Premanathan M. Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy. J Nanopart Res; 2012.14:1063.
26. 25. Ye R, Xu H, Wanb C, Peng S, Wang L, Xu H, et al. Antibacterial activity and mechanism of action of e-poly-L-lysine. Biochem Biophys Res Commun; 2013.439:148-53.
27. 26. Liu H, Pei H, Han Z, Feng G, Li D. The antimicrobial effects and synergistic antibacterial mechanism of the combination of ε-Polylysine and nisin against Bacillus subtilis. Food Control; 2015.47:444-50.
28. 27. Dielbandhoesing SK, Zhang H, Caro LHP, Vander JM, Klis FM, Verrips CT, et al. Specific cell wall proteins confer resistance to nisin upon yeast cells. Appl Environ Microbiol; 1998.64(10):4047-52.
29. 28. Ghasemi B, Beyzaei H, Hashemi SH, Askari VR. [Study on antibacterial effect of new thiazole and imidazole derivatives on zoonoses bacterial pathogen]. J Sabzevar Uni Med Sci; 2017.23(5):762-9. [Persian].
30. 29. Zha GF, Leng J, Darshini N, Shubhavathi T, Vivek HK, Asiri AM. Synthesis, SAR and molecular docking studies of benzo[d]thiazolehydrazones as potential antibacterial and antifungal agents. Bioorg Med Chem Lett; 2017.27:3148-55.
31. 30. Khare R, Sharma J, Sharma A. Synthesis, Characterization, and antibacterial activity of some thiazoles derived from allyl thioureas. Russ J Gen Chem; 2016.86(3):702-7.
32. 31. Malani K, Thakkar SS, Thakur MC, Ray A, Doshi H. Synthesis, characterization and in silico designing of diethyl-3- methyl-5-(6-methyl-2-thioxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carbox amido)thiophene-2,4-dicarboxylate derivative as anti-proliferative and anti-microbial agents. Bioorg Chem; 2016.68:265-74.
33. 32.‌‌ Elumalaia K, Ashraf-Ali M, Srinivasan S, Elumalai M, Eluri K. Antimicrobial and in vitro cytotoxicity of novel sulphanilamide condensed 1,2,3,4-tetrahydropyrimidines. J Taibah Uni Sci; 2017.11(1):46-56.
34. 33. Bhoi MN, Borad MA, Pithawala EA, ModiS, Patel HD. Synthesis of N-(7-chloroquinolin-4-yl)-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5- carbohydrazide derivatives as potent antibacterial agents. Int Lett Chem Phys Astron; 2015.56:82-90.
35. 34. Madabhushi S, Mallu KK, Vangipuram VS, Kurva S, Poornachandra Y, Ganesh Kumar C. Synthesis of novel benzimidazole functionalized chiral thioureas and evaluation of their antibacterial and anticancer activities. Bioorg Med Chem Lett; 2014.24(20):4822-5.
36. 35. Suleymanoglu N, Unver Y, UstabasR, DirekelS, Bingol-Alpaslan Y. Theoretical and antimicrobial activity study for ethyl{4-[3-(1H-imidazole-1-yl)propyl]-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}acetate. Spectrosc Lett; 2017.50(2):96-101.
37. 36. Letafat B, Mohammadhosseins N, Asadipoup A, Foroumadi A. Synthesis and in vitro antibacterial activity of new 2-(1-Methyl-4-nitro-1H-imidazol-5-ylsulfonyl)-1,3,4-thiadiazoles. E J Chem; 2011.8(3):1120-3.
38. 37. Shahid HA, Jahangir S, Yousuf S, Hanif M, Sherwan SK. Synthesis, crystal structure, structural characterization and in vitro antimicrobial activities of 1-methyl-4-nitro-1H-imidazole. Arab J Chem; 2016.9(5):668-75.

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb